Home Integrated Clinical Trial Drug Supply Solutions: Complex Case Studies and Strategic Insights

Integrated Clinical Trial Drug Supply Solutions: Complex Case Studies and Strategic Insights

Oct 11, 2023 08:00 CST Updated 08:00

Against the backdrop of further refined national policies and increased incentives for new drug development, a growing number of pharmaceutical companies are engaging in the research and development (R&D) of novel therapeutics. However, new drug R&D has long been plagued by high costs and prolonged timelines, with investments amounting to hundreds of millions of yuan facing a failure rate as high as 75%. How can clinical research organizations achieve precise control, dynamic balance, cost reduction, and efficiency enhancement? How can they efficiently advance clinical trials for new drugs? Only by adopting an integrated mindset that emphasizes resource integration and leverages core strengths can the pain points in clinical research be effectively addressed!


To Explore the Impact of Integrated Solutions on Drug Supply in Clinical ResearchValue andSignificance,Wednesday, October 18, 2023, 15:00–16:00Arterial Selection Joins Hands with Shanhoo Health, to jointly host a live online public lecture. This session will"Integrated Solutions for Clinical Trial Drug Supply: Sharing Complex Case Studies"Focusing on this theme, we share Shanhoo Health’s pioneering integrated solution that bridges the three major domains of clinical trials—GCP, GSP, and GMP—covering the entire lifecycle of clinical trial drug management and truly achieving a complete online-to-offline closed-loop management system for pharmaceuticals.


Scan the QR code in the poster below to register for the live stream:


9999999.jpg


Core Content of This Public Lecture


1. Introduction to the Concept of Integrated Clinical Trial Drug Supply

2. Drug Supply Stakeholders and Relationships

3. Sharing of Complex Cases

4. Analysis of Pain Points and Challenges in Drug Supply, and Solutions


Audience for This Open Class Trial Session


Sponsors of clinical projects, pharmaceutical companies, founders, general managers, and directors of CROs

[Recommendation: ★★★★★]


Heads of Clinical Trial Departments at Clinical Project Sponsors, Pharmaceutical Companies, and CROs

[Recommendation: ★★★★★]


If you belong to the above-mentioned groups, be sure not to miss this information-packed open lecture.


Guest Introduction


Sun Jialin | Partner & Chief Operating Officer, Shanhu Health Technology Co., Ltd.


杉互讲师 孙家林.jpg


Holding dual master’s degrees in Medicine and Business Administration (MBA), with 20 years of experience in clinical research, currently overseeing operations and drug supply teams. Prior to joining Shanhu, served in the Medical Department at Hengrui Medicine and as a Therapeutic Area Leader (TAL) at Roche’s Asia-Pacific R&D Center. Led and participated in strategic planning for multiple clinical studies, covering oncology immunotherapy, central nervous system disorders, and metabolic diseases. Possesses extensive expertise in clinical trial project management, therapeutic area strategic planning, Interactive Response Technology (IRT) systems, and investigational medicinal product supply chain management.


About Shanhu Health


Shanhu Health is dedicated to providing the highest-quality digital products for clinical medical research, including IP4CAST, IRT, WMS, EDC, eCOA, and drug management services. As a leading provider in China of integrated solutions for clinical data and drug management in new drug research, Shanhu has supported over 1,000 clinical studies, serving more than 1,000 cities, 2,000+ research centers, and over 1 million participants globally, with many of these being large-scale international Phase III trials. Founded in 2015 and headquartered in the Shanghai Zhangjiang Free Trade Zone, Shanhu operates R&D centers, operational hubs, and pharmaceutical warehousing facilities in Suzhou, Guangzhou, Hangzhou, and Nanjing. For eight years, the company has focused on delivering high-quality digital healthcare solutions, striving to become—and be recognized as—the most dynamic health technology company worldwide.


About Artery Selection Open Course


“VCBeat Select Open Course” is one of the brand columns under VCBeat’s “VCBeat Select” initiative. Focusing on pain points in the healthcare sector and the exploration of systematic solutions, it leverages an online live-streaming platform for knowledge sharing and exchange. By continuously inviting seasoned industry practitioners and experts to collaboratively develop a series of thematic courses, it aims to provide healthcare enterprises with in-depth, high-value, and practical content. VCBeat Select Open Course: Making the selection of knowledge simpler.


Live Stream Reservation


Scan the QR code below to contact the assistant and schedule a live stream.

(If already added, please proactively contact the assistant)


10.18 杉互公开课第2期.png